Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | LSS | P48449 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | LIPA | P38571 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19721994 | 1.00 | CYP1A2 (0.39) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9648982 | 0.83 | CYP1A2 (0.38) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9649093 | 0.83 | CYP1A2 (0.38) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL8011866 | 0.83 | CYP1A2 (0.38) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9649108 | 0.83 | CYP1A2 (0.38) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL10707112 | 0.82 | CYP1A2 (0.54) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL10346757 | 0.82 | CYP1A2 (0.54) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL10346759 | 0.82 | CYP1A2 (0.54) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL9649298 | 0.81 | CYP1A2 (0.38) | CYP1A2PKMHTTLMNAMAPK1 | |
| SCHEMBL10702696 | 0.80 | CYP1A2 (0.52) | CYP1A2PKMHTTLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | JNC CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20190292455-A1 | LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM, AND LIQUID CRYSTAL MEDIUM CONTAINING SAME | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-20190292462-A1 | LIQUID CRYSTAL DISPLAY DEVICE INCLUDING LIQUID CRYSTAL MEDIUM CONTAINING LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | CYP1A2 3538/4885PKM 1138/4885HTT 4783/4885 |
| US-20190292462-A1 | LIQUID CRYSTAL DISPLAY DEVICE INCLUDING LIQUID CRYSTAL MEDIUM CONTAINING LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM | ACP1, MAPK1, PLD1 | CYP1A2 3538/4885PKM 1138/4885HTT 4783/4885 |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | ACP1, MFAP1, PHOSPHO1 | CYP1A2 4252/4885PKM 785/4885HTT 4691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.